Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

Thomas R. Collins  |  August 1, 2014

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsRheumatoid Arthritis Tagged with:BiologicsCollinsEULARMethotrexateRheumatoid arthritisrheumatologistrheumatologyrituximabsarilumab

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel  |  July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Filed under:Biologics/DMARDsConditionsDrug UpdatesEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:AC&RAmerican College of Rheumatology (ACR)BiologicsdrugEULARGlucocorticoidsLupusprednisoneRheumatoid arthritisrheumatologistrituximabSLESystemic lupus erythematosus

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP  |  June 1, 2014

Legislative news on biosimilars, safety warning on epidural corticosteroid injections, and other drug updates rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPsoriatic ArthritisResearch Rheum Tagged with:anti-inflammatoryBiologicsBiosimilarscelecoxib (Elyxyb)corticosteroid psychosisMethotrexatePsoriatic ArthritisradiographraloxifeneResearchrituximabSafety

Lessons Learned from a Patient with Rheumatoid Arthritis

Sarah Troxell, RN, BSN  |  June 1, 2014

Sarah Troxell, RN, BSN, imparts what she’s learned about RA and medication management, assembling a team of health professionals and battling other health issues

Filed under:ConditionsOther Rheumatic ConditionsProfilesRheumatoid Arthritis Tagged with:Antiphospholipid Antibody Syndrome (APS)Association of Rheumatology Professionals (ARP)BiologicsHughes SyndromeMethotrexateprednisoneProfileRARheumatoid arthritisrheumatologistrituximabTroxell

Fellow’s Forum Case Report: Takayasu’s Arteritis

Ashwini Komarla, MD; Michael George, MD; Antoine Sreih, MD; & Chris Derk, MD, MS  |  May 1, 2014

How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease

Filed under:ConditionsVasculitis Tagged with:drugGiant Cell ArteritisGlucocorticoidsimaginginfliximablarge-vessel vasculitisMethotrexatePainpatient careprednisonerheumatologistrituximabTakayasu’s ArteritistocilizumabTreatmentVasculitis

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD  |  May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Ankylosing Spondylitisanti-inflammatoryaxial skeletal inflammationaxial spondyloarthritis (SpA)DrugsepidemiologyimagingPainpatient careradiographResearchrheumatologistrituximabterminologyTofacitinib

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2014

Information on new approvals and medication safety that rheumatologists need to know

Filed under:Biologics/DMARDsConditionsDrug UpdatesPain SyndromesRheumatoid Arthritis Tagged with:ApprovalsBiosimilarsdrugFDAFibromyalgiainfliximabPipelineRheumatoid arthritisrheumatologistrheumatologyrituximabSafety

Why Antiphospholipid Antibody Syndrome Should Be On Your Radar

Imad Uthman, MD, MPH, and Munther Khamashta, MD, PhD  |  February 1, 2014

With a wide range of clinical manifestations and frequent occurrence among rheumatology patients, APS is one for rheumatologists to watch

Filed under:ConditionsOther Rheumatic ConditionsSystemic Lupus Erythematosus Tagged with:anti-inflammatoryAntiphospholipid Antibody Syndrome (APS)DiagnosisdrugHughes SyndromeHYDROXYCHLOROQUINEpatient carerheumatologistrheumatologyrituximabSystemic lupus erythematosusTreatment

Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life

Deborah M. Levy, MD, MS  |  January 1, 2014

Differences in disease manifestations, severity, and management require special consideration from rheumatologists who treat children and adolescents with systemic lupus erythematosus

Filed under:ConditionsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:drugHYDROXYCHLOROQUINELupusMethotrexatepatient carePediatricPediatricsprednisonerheumatologistrituximabSLESystemic lupus erythematosusTreatment

Inflammatory Myopathies Difficult to Diagnose, Treat

Jonathan Jones, MD, and Robert Wortmann, MD  |  December 1, 2013

Without a single set of diagnostic criteria for identifying polymyositis, dermatomyositis, or myositis and scant evidence-based therapeutic guidelines, these rare muscle diseases can be hard to manage

Filed under:ConditionsMyositisOther Rheumatic Conditions Tagged with:dermatomyositisDiagnosisinflammatory myopathymyositispolymyositisrheumatologyTreatment

  • « Previous Page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences